Institutional research desks maintain bullish GMED stock price forecast scenarios, tied to expanding product adoption rates in major hospital networks. Pipeline maturation is expected to accelerate top-line growth. To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). We just received data on a new analyst forecast for $GMED. Needham gave a rating of 'Hold' for $GMED. Valuation metrics indicate GMED trades at a forward P/E multiple of 28, slightly above industry average. Still, the GMED stock price forecast accounts for premium positioning due to product differentiation in the minimally invasive spine surgery market.